Coherus Oncology
CHRS
CHRS
201 hedge funds and large institutions have $1.23B invested in Coherus Oncology in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 73 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more capital invested
Capital invested by funds: $1.22B → $1.23B (+$2.72M)
27% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 73
Holders
201
Holding in Top 10
–
Calls
$1.14M
Puts
$726K
Top Buyers
| 1 | +$17.8M | |
| 2 | +$11.6M | |
| 3 | +$10M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.27M |
| 5 |
BlackRock
New York
|
+$5.25M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$7.68M | |
| 3 | -$4.23M | |
| 4 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$3.49M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.39M |